Vancomycin in patients with hemodialysis
Reading File
Finding Sources
Finding Sources
Searching PubMed
vancomycin hemodialysis dosing pharmacokinetics
Reading File
Reading File
Finding Sources
Searching PubMed
vancomycin hemodialysis dosing AUC monitoring
Reading File
Reading File
Reading Article
PMID: 40811453
Reading File
Loading Image
I now have all the information needed for a thorough, well-cited answer. Here it is:
Vancomycin in Hemodialysis Patients
Pharmacokinetics & Why Hemodialysis Changes Everything
Vancomycin is a glycopeptide antibiotic excreted almost entirely (~90%) by glomerular filtration, with a normal elimination half-life of about 6 hours. In anuric patients, the half-life extends dramatically - up to 6-10 days - because renal clearance is essentially zero. This means dosing intervals must be radically prolonged compared to patients with normal renal function. - Goodman & Gilman's, p. 1180; Katzung, p. 1256
Protein binding: ~30% bound to plasma proteins, leaving a large free fraction available for dialytic removal.
Effect of Dialysis Membrane Type
Not all hemodialysis removes vancomycin equally. This is the single most important practical point:
| Dialyzer Type | Vancomycin Removal |
|---|---|
| Low-flux (cellulose) | Minimal removal - old "q7d dosing" still applied |
| High-flux (synthetic, e.g., polysulfone) | Significant removal - 30-40% per session |
| High-efficiency dialysis | Substantial clearance (variable) |
High-flux hemodialysis, now used in most dialysis centers, significantly clears vancomycin and requires supplemental post-dialysis doses. - Katzung, p. 1256; Comprehensive Clinical Nephrology 7th Ed., p. 962
Dosing Strategy
Loading Dose
A loading dose is needed regardless of renal function to rapidly achieve therapeutic concentrations:
- Standard: 25-30 mg/kg IV (some protocols use a flat 1 g)
- Higher loading doses (25-30 mg/kg) are preferred for serious infections (endocarditis, bacteremia, meningitis)
Maintenance Dosing
The classic regimen cited in guidelines:
1 g loading dose, then 500 mg after each dialysis session - adjusted based on serum levels. - Katzung, p. 1257
In practice, the actual supplemental dose depends on:
- Pre-dialysis (trough) vancomycin level
- Type of dialyzer used
- Duration and frequency of sessions
- Target PK/PD index being monitored
Therapeutic Drug Monitoring (TDM)
AUC/MIC vs. Trough Monitoring
There has been a major paradigm shift in vancomycin TDM, now reflected in current guidelines:
- Old approach: Target trough levels of 15-20 mcg/mL for serious infections (MRSA)
- Current preferred approach: Target an AUC/MIC ratio of 400-600 mg·h/L (some guidelines quote ≥400 mg·h/L as minimum)
The rationale: Trough-only monitoring overestimates exposure risk and is associated with higher nephrotoxicity rates. AUC-based dosing reduces nephrotoxicity while maintaining efficacy. - Katzung, p. 1256
In Hemodialysis Patients - A Key Knowledge Gap
A 2026 scoping review (Corrêa et al., Ther Drug Monit 2026) found that:
- The AUC/MIC 400-600 target has no strong validated evidence specifically for patients on renal replacement therapy
- Target attainment is suboptimal in most settings regardless of the TDM method used
- Intradialytic vancomycin removal is highly variable depending on RRT modality, session parameters, and dialyzer characteristics
- Model-informed precision dosing (MIPD) is an emerging strategy to optimize therapy in this population
A 2024 RCT (Zamoner et al., Sci Rep 2024) specifically studied vancomycin AUC/MIC in patients with AKI on hemodialysis, confirming that standard dosing approaches require modification in this population.
Practical TDM Approach for HD Patients
- Draw pre-dialysis level (this is the trough surrogate)
- Draw post-dialysis level (to quantify dialytic removal)
- Supplement if pre-dialysis trough falls below target (commonly <15 mcg/mL for serious infections, or as guided by AUC software)
- Typical supplemental dose: 250-500 mg after each session (titrated)
Adverse Effects Relevant to Dialysis Patients
Nephrotoxicity
In patients still making some urine (residual renal function), vancomycin poses a risk:
- Primary mechanism: accumulation in proximal tubular cells via basolateral secretion → oxidative stress → apoptosis
- Pathology: ATN (predominant in experimental models); case reports also show acute interstitial nephritis
- Risk factors: trough >15 mcg/mL, total daily dose >4 g, concurrent nephrotoxins (especially aminoglycosides), piperacillin-tazobactam co-administration, critical illness
- Vancomycin-associated AKI is generally reversible
- If levels are dangerously high: high-flux HD can be used for drug removal - Comprehensive Clinical Nephrology 7th Ed., p. 962-963
Ototoxicity
- Keep peak levels <60 mcg/mL to minimize risk
- Risk increases with concurrent aminoglycosides or loop diuretics (especially relevant in dialysis patients who often receive both)
- Katzung, p. 1257; Cummings Otolaryngology
Infusion-Related ("Red Man Syndrome")
- Histamine release causing flushing, erythema of face/neck/upper trunk
- Prevention: infuse over 1-2 hours (preferred) or pretreat with diphenhydramine
Special Considerations in HD Patients
| Issue | Consideration |
|---|---|
| Timing of dose | Give at end of dialysis or post-dialysis to avoid immediate drug removal |
| High-flux vs. low-flux | Always clarify membrane type - it dramatically changes clearance |
| CRRT vs. IHD | Continuous RRT removes vancomycin continuously; different dosing needed |
| Residual kidney function | If any urine output remains, clearance is higher |
| MRSA treatment | Standard regimen often insufficient; higher loading doses and careful TDM required |
| VRE infections | Vancomycin ineffective - use daptomycin or linezolid instead |
Summary Table: Normal vs. HD Patient
| Parameter | Normal Renal Function | Hemodialysis |
|---|---|---|
| Elimination t½ | ~6 hours | ~6-10 days (anuric) |
| Dosing interval | q8-12h | After each dialysis session |
| Typical dose | 30-60 mg/kg/day | 1 g load, then ~500 mg post-HD |
| TDM target | AUC/MIC 400-600 | Same target, but evidence weak |
| Trough target | 15-20 mcg/mL (serious infections) | Pre-HD trough guided |
| Dialytic clearance | N/A | High with high-flux membrane |
Note on recent evidence: The 2026 scoping review (PMID 40811453) highlights that optimal TDM targets in intermittent HD patients remain an active research area with no strong consensus, and model-informed precision dosing (MIPD) software is increasingly recommended. Current standard protocols (trough-based or estimated AUC) should be used with awareness of their limitations in this population.
Is it daily or 48-72 hours?
Finding Sources
Searching PubMed
vancomycin intermittent hemodialysis dosing interval frequency
Finding Sources
Searching the Web
vancomycin dosing hemodialysis frequency daily vs 48-72 hours high-flux membrane guidelines
Great - the sources are clear and consistent. Here's the direct answer:
Vancomycin Dosing Frequency in HD: The Answer
Neither strictly daily nor 48-72 hours - the correct answer is after each dialysis session, which practically means every 48-72 hours for most patients on a standard thrice-weekly HD schedule.
Here's why the old "every 5-7 days" concept was wrong, and how to think about this correctly:
The Key Variable: Dialysis Membrane
| Membrane | Vancomycin Removal | Dosing Interval |
|---|---|---|
| Low-flux (old cellulose) | Minimal | Once weekly (now outdated) |
| High-flux (modern, polysulfone) | 30-50% per session | After each HD session (~q48-72h) |
The shift from low-flux to high-flux membranes completely changed vancomycin dosing. Weekly dosing with high-flux HD produces subtherapeutic levels after 5-7 days and should be abandoned. A landmark study of 130 courses confirmed this - weekly dosing with high-flux membranes was inadequate. - Kidney Int 1996, PMID 8872968
Practical Dosing Regimen (High-Flux HD - Standard Today)
- Loading dose: 15-25 mg/kg IV (given post-dialysis or on a non-dialysis day)
- Supplemental doses: given after each dialysis session, titrated by pre-dialysis trough:
| Pre-HD Trough (mcg/mL) | Supplemental Dose |
|---|---|
| < 5 | 12.5 mg/kg |
| 5-10 | 10 mg/kg |
| 10-15 | 7.5 mg/kg |
| 15-20 | 5 mg/kg |
| 20-25 | 2.5 mg/kg |
| > 25 | Hold - no dose needed |
(Stanford Children's HD Vancomycin Protocol)
For most standard 3x/week HD patients (Mon/Wed/Fri or Tue/Thu/Sat), this translates to dosing every 48-72 hours, matching dialysis session days. The dose is always given post-dialysis, not pre- or during, to avoid wasting drug that would be immediately cleared.
Why Not Daily?
Daily dosing would be needed only if:
- The patient is on daily HD (some AKI-on-HD patients)
- There is significant residual renal function still clearing the drug
- Using CRRT (continuous RRT - very different pharmacokinetics, often requires continuous or q24h infusions)
For typical anuric patients on thrice-weekly HD with high-flux membranes, daily dosing would be excessive between sessions and inadequate only if sessions were more frequent.
Bottom line: Think of it as "after every dialysis session" rather than a fixed time interval. With standard 3x/week HD + high-flux membrane, that works out to every 48-72 hours. - Katzung 16th Ed.; Goldman-Cecil Medicine
This is a shared conversation. Sign in to Orris to start your own chat.